Literature DB >> 18665346

WNT signalling is both an inducer and effector of glucagon-like peptide-1.

B Gustafson1, U Smith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18665346     DOI： 10.1007/s00125-008-1109-6

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  7 in total

1.  Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes.

Authors:  Valeriya Lyssenko; Roberto Lupi; Piero Marchetti; Silvia Del Guerra; Marju Orho-Melander; Peter Almgren; Marketa Sjögren; Charlotte Ling; Karl-Fredrik Eriksson; Asa-Linda Lethagen; Rita Mancarella; Göran Berglund; Tiinamaija Tuomi; Peter Nilsson; Stefano Del Prato; Leif Groop
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

2.  Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes.

Authors:  Struan F A Grant; Gudmar Thorleifsson; Inga Reynisdottir; Rafn Benediktsson; Andrei Manolescu; Jesus Sainz; Agnar Helgason; Hreinn Stefansson; Valur Emilsson; Anna Helgadottir; Unnur Styrkarsdottir; Kristinn P Magnusson; G Bragi Walters; Ebba Palsdottir; Thorbjorg Jonsdottir; Thorunn Gudmundsdottir; Arnaldur Gylfason; Jona Saemundsdottir; Robert L Wilensky; Muredach P Reilly; Daniel J Rader; Yu Bagger; Claus Christiansen; Vilmundur Gudnason; Gunnar Sigurdsson; Unnur Thorsteinsdottir; Jeffrey R Gulcher; Augustine Kong; Kari Stefansson
Journal:  Nat Genet       Date:  2006-01-15       Impact factor: 38.330

3.  Transcriptional activation of the proglucagon gene by lithium and beta-catenin in intestinal endocrine L cells.

Authors:  Zuyao Ni; Younes Anini; Xianjun Fang; Gordon Mills; Patricia L Brubaker; Tianru Jin
Journal:  J Biol Chem       Date:  2002-11-05       Impact factor: 5.157

Review 4.  The WNT signalling pathway and diabetes mellitus.

Authors:  T Jin
Journal:  Diabetologia       Date:  2008-08-12       Impact factor: 10.122

5.  Glucagon-like peptide-1 activation of TCF7L2-dependent Wnt signaling enhances pancreatic beta cell proliferation.

Authors:  Zhengyu Liu; Joel F Habener
Journal:  J Biol Chem       Date:  2008-01-23       Impact factor: 5.157

6.  Reduced incretin effect in type 2 diabetes: cause or consequence of the diabetic state?

Authors:  Filip K Knop; Tina Vilsbøll; Patricia V Højberg; Steen Larsen; Sten Madsbad; Aage Vølund; Jens J Holst; Thure Krarup
Journal:  Diabetes       Date:  2007-05-18       Impact factor: 9.461

7.  Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms.

Authors:  S A Schäfer; O Tschritter; F Machicao; C Thamer; N Stefan; B Gallwitz; J J Holst; J M Dekker; L M 't Hart; L M t'Hart; G Nijpels; T W van Haeften; H U Häring; A Fritsche
Journal:  Diabetologia       Date:  2007-07-28       Impact factor: 10.122
  7 in total
  6 in total

1.  Metabolic improvement and liver regeneration by inhibiting CXXC5 function for non-alcoholic steatohepatitis treatment.

Authors:  Seol Hwa Seo; Eunhwan Kim; Minguen Yoon; Soung-Hoon Lee; Byung-Hyun Park; Kang-Yell Choi
Journal:  Exp Mol Med       Date:  2022-09-16       Impact factor: 12.153

2.  The Incretins and Pancreatic beta-Cells: Use of Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide to Cure Type 2 Diabetes Mellitus.

Authors:  Mi-Hyun Kim; Moon-Kyu Lee
Journal:  Korean Diabetes J       Date:  2010-02-28

Review 3.  Glucagon-like peptide-1(GLP-1) receptor agonists: potential to reduce fracture risk in diabetic patients?

Authors:  Guojing Luo; Hong Liu; Hongyun Lu
Journal:  Br J Clin Pharmacol       Date:  2016-01       Impact factor: 4.335

4.  WNT/beta-catenin increases the production of incretins by entero-endocrine cells.

Authors:  J M García-Martínez; A Chocarro-Calvo; C M Moya; C García-Jiménez
Journal:  Diabetologia       Date:  2009-07-07       Impact factor: 10.122

5.  The involvement of the wnt signaling pathway and TCF7L2 in diabetes mellitus: The current understanding, dispute, and perspective.

Authors:  Wilfred Ip; Yu-Ting Alex Chiang; Tianru Jin
Journal:  Cell Biosci       Date:  2012-08-14       Impact factor: 7.133

Review 6.  Inflammation Meets Metabolic Disease: Gut Feeling Mediated by GLP-1.

Authors:  Tamara Zietek; Eva Rath
Journal:  Front Immunol       Date:  2016-04-22       Impact factor: 7.561
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.